World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02362256
Date of registration: 18/01/2015
Prospective Registration: No
Primary sponsor: Vilnius University
Public title: The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
Scientific title: The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism With Naltrexone and Sedation
Date of first enrolment: May 2014
Target sample size: 60
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02362256
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Lithuania
Contacts
Name:     JUOZAS IVASKEVICIUS, PROFESSOR
Address: 
Telephone:
Email:
Affiliation:  Vilnius University Clinic of Anaesthesiology and Intensive Care
Name:     ROBERTAS BADARAS, MD
Address: 
Telephone:
Email:
Affiliation:  Vilnius University Clinic of Anaesthesiology and Intensive Care
Key inclusion & exclusion criteria

Inclusion Criteria:

- Opiate addiction

- Use of short-acting opiate (morphine or heroine)

- Age > 18 years

- Length of opiate addiction > 1 year

- Patient can make a decision for detoxification and has a capacity to consent for
procedure

- Written consent for procedure

Exclusion Criteria:

- Polyvalent addiction

- Pregnancy or breast feeding

- Cardiovascular pathology

- Acute or chronic kidney disease

- Decompensated liver pathology (jaundice, ascites, hepatic encephalopathy)

- Infective complications of opiate addiction (pneumonia, phlegmon, abscess,
thombophlebitis, sepsis)

- Malnutrition (Nutritional risk screening 2002 score =3)

- Diabetes mellitus

- Previous history of psychosis

- Glasgow coma scale < 15

- Abdominal surgical intervention during last 30 days

- Cumulative buprenorphine dose for stabilization < 8 mg

- Positive test for psychoactive substances during treatment

- Refusal to participate in study at any point of it



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Opiate Addiction
Intervention(s)
Drug: Clonidine
Drug: Naltrexone
Drug: Lorazepam
Primary Outcome(s)
Adrenocorticotropic hormone (ACTH) levels [Time Frame: 2 days]
Cortisol levels [Time Frame: 2 days]
Secondary Outcome(s)
Stress response levels according to blood pressure [Time Frame: 4 days]
Changes of sodium concentration due to stress response [Time Frame: 4 days]
Objective Opiate Withdrawal Scale (OOWS) [Time Frame: 4 days]
Changes of glucose concentration due to stress response [Time Frame: 4 days]
Changes of magnesium concentration due to stress response [Time Frame: 4 days]
Stress response levels according to respiratory rate [Time Frame: 4 days]
Subjective Opiate Withdrawal Scale (SOWS) [Time Frame: 4 days]
Changes of chloride concentration due to stress response [Time Frame: 4 days]
Changes of potassium concentration due to stress response [Time Frame: 4 days]
Stress response levels according to heart rate [Time Frame: 4 days]
Secondary ID(s)
158200-01-443-124
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history